13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

Page 9 of 9

Page 9 of 9 – SEC Filing

SIGNATURE

After reasonable inquiry
and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true,
complete and correct.

Dated:  March 19, 2018
SARISSA CAPITAL MANAGEMENT LP
By: /s/ Mark DiPaolo
Name: Mark DiPaolo
Title: General Counsel
SARISSA CAPITAL OFFSHORE MASTER FUND LP
By: Sarissa Capital Offshore Fund GP LLC, its general partner
By: /s/ Mark DiPaolo
Name: Mark DiPaolo
Title: Authorized Person
SARISSA CAPITAL CATAPULT FUND LLC
By: Sarissa Capital Management LP, its managing member
By: /s/ Mark DiPaolo
Name: Mark DiPaolo
Title: General Counsel
/s/Alexander J. Denner
Alexander J. Denner

Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)

Page 9 of 9